Metabolic and genetic factors modulating subject specific LDL-C responses to plant sterol therapy11 This article is an invited review for the Journal's Made In Canada section. The authors gratefully acknowledge the training that was acquired at the Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba. We would specifically like to thank Dr. Peter Jones for his mentorship and significant contribution to the research contained within this manuscript.

Author： Rideout Todd C.   Harding Scott V.   Mackay Dylan S.  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.90, Iss.5, 2012-05, pp. : 509-514

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Campbell Library Resource Guide: Nutraceuticals and Functional Foods

By Weaver P.   Features Submission Haworth C.  

Journal of Nutraceuticals, Vol. 4, Iss. 3-4, 2005-02 ,pp. : 155-160

Haworth Press

Access to resources Recommend Favorite

Effectiveness and Safety of Ezetimibe Added to Statin Therapy in Patients with Primary Dyslipidaemia not Achieving the LDL-C Treatment Goal on Statin Monotherapy

By González Carlos A.   Rubio-Guerra Alberto F.   Pavía Abel   Redding Francisco J.   Cervantes José L.   Zacarías José L.   Yza Rubén   Carranza Jaime   Fernández Pedro   Morales Enrique   Robles Francisco J.   Leyva José L.   Rodríguez Leticia  

Clinical Drug Investigation, Vol. 27, Iss. 5, 2007-01 ,pp. : 333-337

Adis International

Access to resources Recommend Favorite

Switch to rosuvastatin leads to greater LDL-C reduction

By  

Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Rosuvastatin: A Review of its Use in the Prevention of Cardiovascular Disease in Apparently Healthy Women or Men with Normal LDL-C Levels and Elevated hsCRP Levels

By Carter Natalie J.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 6, 2010-12 ,pp. : 383-400

Adis International

Access to resources Recommend Favorite

Research Highlights: CYP2C19 genetic variants and clopidogrel responsiveness in acute coronary syndrome: are we ready for individualized therapy?

By Giusti Betti   Gori Anna Maria   Marcucci Rossella   Abbate Rosanna  

Pharmacogenomics, Vol. 10, Iss. 7, 2009-07 ,pp. : 1131-1133

Future Medicine

Access to resources Recommend Favorite